Results 221 to 230 of about 90,511 (304)

Personalised Procedures for Thoracic Radiotherapy

, 2021
openaire   +1 more source

Analysis of SWI Complex Subunits in 69 Cases of TTF‐1 Negative Non‐Small Cell Lung Carcinoma

Diagnostic Cytopathology, Volume 54, Issue 4, Page 278-284, April 2026.
ABSTRACT Non‐small cell lung carcinomas, not otherwise specified (NSCLC‐NOS) with a specific signature including high‐grade hepatoid/clear cell morphology, negative lung panel mutational analysis, negative TTF‐1/Napsin A staining can be reported as a morphologic variant of an aggressive carcinoma with loss of one of the subunits of the SWI/SNF ...
Ramin Zargham, Feng (Selina) Ji, Tarek Bismar   +2 more
wiley   +1 more source

Brief Report of a New Anatomical Region at Risk in Thoracic Radiotherapy: From Discovery to Implementation. [PDF]

JTO Clin Res Rep
Banfill K, Marchant T, McWilliam A, Wood J, Schmitt M, Abravan A, Price G, van Herk M, Faivre-Finn C.   +8 more
europepmc   +1 more source

Effects of artificial intelligence assistance on endoscopist performance: Comparison of diagnostic performance in superficial esophageal squamous cell carcinoma detection using video‐based models

DEN Open, Volume 6, Issue 1, April 2026.
Abstract Objectives Superficial esophageal squamous cell carcinoma (ESCC) detection is crucial. Although narrow‐band imaging improves detection, its effectiveness is diminished by inexperienced endoscopists. The effects of artificial intelligence (AI) assistance on ESCC detection by endoscopists remain unclear.
Naoki Aoyama, Keiichiro Nakajo, Maasa Sasabe, Atsushi Inaba, Yuki Nakanishi, Hiroshi Seno, Tomonori Yano   +6 more
wiley   +1 more source

Integrating knowledge-based planning and noncoplanar oblique VMAT arcs: A study of dose to the heart and immune cells in thoracic radiotherapy. [PDF]

Tech Innov Patient Support Radiat Oncol
Diedrich B, Roper J, Hopkins B, Tian S, Momin S, Schreibmann E, Kesarwala AH, Luca K.   +7 more
europepmc   +1 more source

Prophylactic Inhaled Pattern Recognition Receptor Agonists Reprogram Lung Epithelial Response and Prevent Type 2 Allergic Inflammation

European Journal of Immunology, Volume 56, Issue 4, April 2026.
Inhaled pretreatment of mouse lungs with immunomodulatory Pam2ODN results in lung epithelial cell epigenetic reprogramming that is associated with attenuation of house dust mite extract (HDM)‐induced cDC2s and moDCs expansion in the lung, causing tolerance against HDM sensitization and restricting Th2‐cell‐induced airway eosinophilic allergic ...
Mbaya Ntita, Celine Shuet Lin Kong, Dalia Hassan, Richa Nayak, Jezreel Pantaleón García, Yongxing Wang, Jichao Chen, Scott E. Evans   +7 more
wiley   +1 more source

Treatment, complications, and outcomes of metastatic disease of the spine: From Patchell to PROMIS [PDF]

, 2019
Buchowski, Jacob M, Wegner, Adam M, Yahanda, Alexander T   +2 more
core   +2 more sources

Benefit of Consolidation Thoracic Radiotherapy in Extensive-Stage Small-Cell Lung Cancer Patients Treated with Immunotherapy: Data from Slovenian Cohort. [PDF]

Int J Mol Sci
Čakš M, Janžič U, Rutar T, Unk M, Demšar A, Mohorčič K, Turnšek N, Matos E, But-Hadžić J.   +8 more
europepmc   +1 more source

Optimizing the integration of modern systemic therapies and advanced radiotherapy techniques in breast cancer management: An expert opinion from the Institut Curie Breast Radiotherapy Group

International Journal of Cancer, Volume 158, Issue 7, Page 1775-1784, 1 April 2026.
Abstract The integration of modern systemic therapies with radiotherapy (RT) represents a promising strategy in breast cancer management, enhancing both locoregional control and systemic disease outcomes. This expert consensus from the Institut Curie Breast Radiotherapy Group focuses exclusively on modern systemic agents, synthesizing current evidence ...
Cezara Cheptea, Pierre Loap, Sofiane Allali, Alain Fourquet, Kim Cao, Youlia Kirova   +5 more
wiley   +1 more source

Platinum and etoposide chemotherapy, durvalumab with thoracic radiotherapy in the first-line treatment of patients with extensive-stage small-cell lung cancer: CHEST-RT (TROG 20.01) Trial - protocol for a phase II study. [PDF]

BMJ Open
Parakh S, Gee H, Lim A, Vinod S, Wheeler C, Rooney B, Montgomery R, Harden S, Moore M, Lehman M, Bettington C, Moodie T, Barber J, Schmidt L, Dizon J, Leigh L, Oldmeadow C, Mitchell P, Hau E.   +18 more
europepmc   +1 more source